Detalles de la búsqueda
1.
Panitumumab plus trifluridine/tipiracil as anti-EGFR rechallenge therapy in patients with refractory RAS wild-type metastatic colorectal cancer: Overall survival and subgroup analysis of the randomized phase II VELO trial.
Int J Cancer
; 153(8): 1520-1528, 2023 10 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37391938
2.
Gut microbiota correlates with antitumor activity in patients with mCRC and NSCLC treated with cetuximab plus avelumab.
Int J Cancer
; 151(3): 473-480, 2022 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35429341
3.
Selective Inhibition of Genomic and Non-Genomic Effects of Thyroid Hormone Regulates Muscle Cell Differentiation and Metabolic Behavior.
Int J Mol Sci
; 22(13)2021 Jul 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34281225
4.
Phenotypic Effects of Homeodomain-Interacting Protein Kinase 2 Deletion in Mice.
Int J Mol Sci
; 22(15)2021 Aug 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34361060
5.
Rare diseases in Italy: analysis of the costs and pharmacotherapy.
Ceska Slov Farm
; 62(4): 159-62, 2013 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-24047143
6.
Pretreatment Plasma Circulating Tumor DNA RAS/BRAF Mutational Status in Refractory Metastatic Colorectal Cancer Patients Who Are Candidates for Anti-EGFR Rechallenge Therapy: A Pooled Analysis of the CAVE and VELO Clinical Trials.
Cancers (Basel)
; 15(7)2023 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37046778
7.
Panitumumab Plus Trifluridine-Tipiracil as Anti-Epidermal Growth Factor Receptor Rechallenge Therapy for Refractory RAS Wild-Type Metastatic Colorectal Cancer: A Phase 2 Randomized Clinical Trial.
JAMA Oncol
; 9(7): 966-970, 2023 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37200022
8.
Final results of the CAVE trial in RAS wild type metastatic colorectal cancer patients treated with cetuximab plus avelumab as rechallenge therapy: Neutrophil to lymphocyte ratio predicts survival.
Clin Colorectal Cancer
; 21(2): 141-148, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35101346
9.
Skin Toxicity as Predictor of Survival in Refractory Patients with RAS Wild-Type Metastatic Colorectal Cancer Treated with Cetuximab and Avelumab (CAVE) as Rechallenge Strategy.
Cancers (Basel)
; 13(22)2021 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34830870
10.
Cetuximab Rechallenge Plus Avelumab in Pretreated Patients With RAS Wild-type Metastatic Colorectal Cancer: The Phase 2 Single-Arm Clinical CAVE Trial.
JAMA Oncol
; 7(10): 1529-1535, 2021 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34382998
11.
Duration of COVID-19: Data from an Italian Cohort and Potential Role for Steroids.
Microorganisms
; 8(9)2020 Aug 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-32878286
12.
Genetic Up-Regulation or Pharmacological Activation of the Na+/Ca2+ Exchanger 1 (NCX1) Enhances Hippocampal-Dependent Contextual and Spatial Learning and Memory.
Mol Neurobiol
; 57(5): 2358-2376, 2020 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-32048166
13.
Discovery of a benzenesulfonamide-based dual inhibitor of microsomal prostaglandin E2 synthase-1 and 5-lipoxygenase that favorably modulates lipid mediator biosynthesis in inflammation.
Eur J Med Chem
; 156: 815-830, 2018 Aug 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30053720
14.
Effects of metabolic stress and ischaemia on the bladder, and the relationship with bladder overactivity.
Scand J Urol Nephrol Suppl
; (215): 84-92, 2004.
Artículo
en Inglés
| MEDLINE | ID: mdl-15545202
Resultados
1 -
14
de 14
1
Próxima >
>>